According to Pharmarise Holdings Corporation latest financial reports the total debt is $38.28M, an decrease of -26.42% to 2022. At the end of 2022 company had $52.03M total debt. This figure represents the debts and financial obligations that Pharmarise Holdings Corporation combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $38.28M | -26.42% |
2022 | $52.03M | -5.79% |
2021 | $55.22M | -3.14% |
2020 | $57.01M | -0.76% |
2019 | $57.45M | - |